Hydrazine Sulfate (PDQ®)–Patient Version
Hydrazine sulfate has shown no anticancer activity in randomized clinical trials. It was reported in some clinical trials to be helpful in treating poor appetite and weight loss due to cancer. Learn more about hydrazine sulfate as a treatment for people with cancer in this expert-reviewed summary.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/6023/syndication
- Syndication ID: 1634
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Saturday, September 14, 2013 at 09:03 AM
- Date Syndication Updated: Saturday, August 29, 2026 at 01:21 AM
Tags
General:
prevention
research
policy
patient
version
hydrazine
sulfate
secondhand smoke
hydrazine sulfate
Quitting Resources
Guidance, Regulations and Compliance
Embed Code Snippet
To get the embed code snippet please Login.
